RA Capital Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $169M | Buy |
|
|||||
|
2025
Q2 | $130M | Buy |
|
|||||
|
2025
Q1 | $196M | Hold |
|
|||||
|
2024
Q4 | $238M | Hold |
|
|||||
|
2024
Q3 | $238M | Hold |
|
|||||
|
2024
Q2 | $160M | Hold |
|
|||||
|
2024
Q1 | $163M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $25.4M | Hold |
|
|||||
|
2021
Q4 | $39.9M | Hold |
|
|||||
|
2021
Q3 | $43.4M | Hold |
|
|||||
|
2021
Q2 | $55.7M | Hold |
|
|||||
|
2021
Q1 | $84.9M | Buy |
|